Quarterly Results

  • Company Name :
Alivus Life Sciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543322
  • NSE Symbol:
  • ALIVUS
  • P/E(TTM):
  • 27.11
  • ISIN Demat:
  • INE03Q201024
  • Div & Yield%:
  • 0.47
  • EPS(TTM):
  • 39.60
  • Book Value(₹):
  • 229.75
  • Market Cap(₹Cr.):
  • 13,164.24
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 649.55 641.84 506.88
Excise Duty 0.00 0.00 0.00
Net Sales 649.55 641.84 506.88
Other Operating Income 0.00 0.00 0.00
Other Income 10.09 10.46 8.53
Total Income 659.63 652.30 515.41
Total Expenditure 451.11 451.54 372.52
PBIDT 208.52 200.76 142.89
Interest 1.26 0.46 0.34
PBDT 207.26 200.31 142.55
Depreciation 15.97 15.16 15.09
Tax 47.88 46.81 30.24
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 1.55 1.38 1.90
Reported Profit After Tax 141.87 136.96 95.32
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 141.87 136.96 95.32
EPS (Unit Curr.) 11.57 11.18 7.78
EPS (Adj) (Unit Curr.) 11.57 11.18 7.78
Calculated EPS (Unit Curr.) 11.58 11.18 7.78
Calculated EPS (Adj) (Unit Curr.) 11.58 11.18 7.78
Calculated EPS (Ann.) (Unit Curr.) 46.31 44.71 31.12
Calculated EPS (Adj) (Ann.) (Unit Curr.) 46.31 44.71 31.12
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 24.51 24.51 24.51
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 32.10 31.28 28.19
PBDTM(%) 31.91 31.21 28.12
PATM(%) 21.84 21.34 18.81